SurModics Inc (SurModics) is a provider of in vitro diagnostic (IVD) and medical device technologies to healthcare sector. The company offers a wide range of advanced balloon catheter, thrombectomy, surface modification coatings and ultra-thin-walled catheter technologies to advance new medical devices, biomedical products and enhance existing devices. SurModics also sells components such as protein stabilizers, antigens, antibodies, surface coatings and substrates for molecular tests and IVD immunoassays. The company commercializes its technologies through license and royalty agreements with other medical device manufacturers. The company produces and distributes surface coatings to the diagnostic and biomedical research markets. SurModics is headquartered in Eden Prairie, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company SurModics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- SurModics Inc Company Overview
- SurModics Inc Company Snapshot
- SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview
- SurModics Inc - Pipeline Analysis Overview
- Business Description
- SurModics Inc - Key Facts
- SurModics Inc - Major Products and Services
- SurModics Inc Pipeline Products by Development Stage
- SurModics Inc Ongoing Clinical Trials by Trial Status
- SurModics Inc Pipeline Products Overview
- 0.018” Radial PTA Balloon Catheter
- 0.018” Radial PTA Balloon Catheter Product Overview
- 0.035” Next Generation Workhorse PTA Catheter
- 0.035” Next Generation Workhorse PTA Catheter Product Overview
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter Product Overview
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter Product Overview
- Avess Arteriovenous Access Drug Coated Balloon (DCB)
- Avess Arteriovenous Access Drug Coated Balloon (DCB) Product Overview
- Cachet
- Cachet Product Overview
- I-vation Sustained Drug Delivery System - TA
- I-vation Sustained Drug Delivery System - TA Product Overview
- Neuraxo Implant
- Neuraxo Implant Product Overview
- Pounce Thrombectomy Device
- Pounce Thrombectomy Device Clinical Trial
- Renal Stent System
- Renal Stent System Product Overview
- Sundance BTK DCB
- Sundance BTK DCB Product Overview
- Sundance BTK DCB Clinical Trial
- SurModics Inc - Key Competitors
- SurModics Inc - Key Employees
- SurModics Inc - Key Employee Biographies
- SurModics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- SurModics Inc, Recent Developments
- Apr 26, 2023: Surmodics reports second quarter of Fiscal Year 2023 financial results; Updates Fiscal Year 2023 financial guidance
- Feb 06, 2023: Surmodics Reports First Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance
- Jan 31, 2023: Surmodics to Host Virtual Annual Meeting of Shareholders
- Aug 23, 2022: Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
- Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
- Feb 09, 2021: Surmodics Reports First Quarter Fiscal 2021 Results
- Oct 27, 2020: Surmodics to Webcast Fourth Quarter Fiscal 2020 Earnings Conference Call on November 4
- Feb 05, 2020: Surmodics reports first quarter Fiscal 2020 results
- Feb 03, 2020: Surmodics names Nusrath Sultana, MD, as Vice President, Clinical Affairs
- Oct 31, 2019: Surmodics reports fourth quarter fiscal 2019 results and issues fiscal 2020 revenue and EPS Guidance
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- SurModics Inc Pipeline Products and Ongoing Clinical Trials Overview
- SurModics Inc Pipeline Products by Equipment Type
- SurModics Inc Pipeline Products by Indication
- SurModics Inc Ongoing Clinical Trials by Trial Status
- SurModics Inc, Key Facts
- SurModics Inc, Major Products and Services
- SurModics Inc Number of Pipeline Products by Development Stage
- SurModics Inc Pipeline Products Summary by Development Stage
- SurModics Inc Ongoing Clinical Trials by Trial Status
- SurModics Inc Ongoing Clinical Trials Summary
- 0.018” Radial PTA Balloon Catheter - Product Status
- 0.018” Radial PTA Balloon Catheter - Product Description
- 0.035” Next Generation Workhorse PTA Catheter - Product Status
- 0.035” Next Generation Workhorse PTA Catheter - Product Description
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter - Product Status
- Advance Serenity 14 Hydrophilic PTA Balloon Dilation Catheter - Product Description
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter - Product Status
- Advance Serenity 18 Hydrophilic PTA Balloon Dilation Catheter - Product Description
- Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Status
- Avess Arteriovenous Access Drug Coated Balloon (DCB) - Product Description
- Cachet - Product Status
- Cachet - Product Description
- I-vation Sustained Drug Delivery System - TA - Product Status
- I-vation Sustained Drug Delivery System - TA - Product Description
- Neuraxo Implant - Product Status
- Neuraxo Implant - Product Description
- Pounce Thrombectomy Device - Product Description
- Pounce Thrombectomy Device - Pounce Thrombectomy System Retrospective Registry
- Renal Stent System - Product Status
- Renal Stent System - Product Description
- Sundance BTK DCB - Product Status
- Sundance BTK DCB - Product Description
- Sundance BTK DCB - A Prospective, Multi-center, Single-arm, Feasibility Study to Assess the Safety and Performance with the SUNDANCE DruG Coated Balloon for the Treatment of De Novo or Restenotic Lesions in Infra-popliteal Arteries
- SurModics Inc, Key Employees
- SurModics Inc, Key Employee Biographies
- SurModics Inc, Other Locations
- SurModics Inc, Subsidiaries
- Glossary
- SurModics Inc Pipeline Products by Equipment Type
- SurModics Inc Pipeline Products by Development Stage
- SurModics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Hydromer Inc
- B. Braun Melsungen AG
- Specialty Coating Systems Inc
- Nihon Kohden Corp
- Immucor Inc
